SELLAS Life Sciences Group, Inc.
USD14.82
-0.63 (-4.09%)
CEO
Angelos Stergiou
IPO Date
2008-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.22
Prev. Close
$15.45
Day Low
$13.34
Day High
$15.88
52W Low
$1.39
52W High
$15.88
Market Cap
$2.76B
Volume
14.05M
| -2.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 468.2% | -600.4% | -0.11 | 0.23 | -0.8 |
| 31 Dec 2022 | FY | 90.0% | -4130.1% | -851.4% | -197.2% | 0.19 | 1.14 | -1.1 |
| 31 Dec 2021 | FY | 97.4% | -272.4% | -101.7% | -78.3% | 0.04 | 4.63 | -4.1 |
| 31 Dec 2020 | FY | 100.0% | -881.9% | -59.9% | -36.4% | 0.04 | 2.99 | -2.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -316.6% | -116.2% | 0.04 | 1.56 | -0.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -527.6% | -163.6% | 0.00 | 0.98 | -0.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -1147.5% | -70.9% | 5.31 | 0.53 | -0.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -82.2% | -35.8% | 0.57 | 1.23 | -2.2 |
| -18.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.9% | -13.2% | 0.01 | 8.28 | -6.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -25.2% | -20.4% | 0.03 | 4.91 | -7.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -20.9% | -16.6% | 0.03 | 4.64 | -4.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -71.2% | -34.7% | 0.11 | 1.72 | -2.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -44.7% | -26.8% | 0.04 | 2.26 | -3.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -256.4% | -49.4% | 0.24 | 1.02 | -2.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -98.8% | -39.2% | 0.08 | 1.49 | -1.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 102.0% | -130.8% | -0.11 | 0.23 | -1.0 |